Search Results
13 protocol(s) meet the specified criteria
102756Not Open *
Testing the Addition of the Oral Medication Ibrutinib to Autologous Stem Cell Transplantation for Patients with Relapsed Diffuse Large B-Cell Lymphoma

Pilot Trial Evaluating the Combination of Reolysin and Carfilzomib in Multiple Myeloma

Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy following Allogeneic Transplant for Patients with FLT3/ITD AML

109376Not Open *
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety, Tolerability, and Efficacy of Combination Treatment of BL-8040 and G-CSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous Transplantation in SubjectS with Multiple Myeloma - GENESIS Study

Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

Phase I/II Study of Treg/Tcon Addback to CD34 Selected Partially Matched Related Donor Stem Cells with Myeloablative Conditioning for High-Risk Hematologic Malignancies

Single-Arm Study to Assess the Safety of Transplantation with Human Placental-Derived Stem Cells Combined with Unrelated and Related Cord Blood in Subjects with Certain Malignant Hematologic Diseases and Non-Malignant Disorders

Multicenter Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome

Pilot Study for the Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) with GDC-0449

Phase III, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide versus Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Phase I, Non-Randomized, Open-Label/Phase II Randomized, Blinded Study of ProTmune versus Non-Programmed Mobilized Peripheral Blood Cells for Allogeneic Hematopoietic Cell Transplantation in Adult Subjects with Hematologic Malignancies